In the News
In partnership with our network partners, together, we have shared research on real-world treatment patterns in breast and non-small cell lung cancer.
Events
Conference
Meet with Syapse at ASCO 2023
June 02, 2023
Come experience the future of cancer care at ASCO 2023! Stop by booth 7159 to chat with the Syapse team and learn how AI and clinical-genomic data sourced directly from 460+ multi-disciplinary community hospitals and 10+ molecular labs are helping improve outcomes for patients with cancer. Let's work together to accelerate evidence generation, improve clinical trial operations, and increase best practice adoption.
Podcast
Understanding the complexities of treating patients with Myelodysplastic Syndrome
June 01, 2023
Dr. Garcia-Manero joins Molly Scannell Bryan to share his experience in managing patients with MDS, the important nuances in treating patients with this diagnosis, and the role real-world data can play in improving care.
Webinar
Practical Considerations When Generating RWE in Oncology: What Does Best-in-Class Look Like?
December 05, 2022
With growing regulatory, payer, and provider acceptance, real world evidence (RWE) continues to generate insights on the usage, safety, risks, and benefits of cancer treatment collected in standard clinical practice, especially from electronic medical records. As these types of data continue to be used for mandated safety studies, innovative study designs such as external comparator arm studies, and HEOR studies with payers and providers, it is important to understand the strengths and limitations of the data to draw the right conclusions. Join us for this webinar covering oncology care in the United States. Experts will discuss gaps in real world databases and identify solutions to address these limitations.
Podcast
Treating Prostate Cancer: A patient-centric approach to improving outcomes
June 01, 2023
Dr. Christopher Logothetis joins Dr. Amol Bhalla to share the advances he’s been able to witness and help create, why we need meaningful real-world data that includes the patient perspective, and what steps we can collectively take to usher in the future of medicine.
Podcast
Treating Breast Cancer with testing, therapies, clinical trials and real-world data
June 01, 2023
Dr. Vicente Valero joins Dr. Anna Berry to discuss how he navigates testing, treatments, and using clinical trials along with real-world data to power decision-making to improve patient care.
Podcast
Treating Non-Small Cell Lung Cancer: Evolution from Chemotherapy to Targeted Therapies
June 01, 2023
Drs. George Simon and Matt Rioth talk about how gaining access to molecular information transformed the practice of medicine, effectively navigating the complexities of clinical trials, and using real-world data to guide treatment decision-making.
Webinar
Syapse Real-World Dialogue: Advancing Patient Care through Real-World Data, Machine Learning, and Systems Biology
September 21, 2022
It’s estimated that less than 5% of adult cancer patients enroll in clinical trials. Due to clinical trial eligibility criteria and access barriers to clinical trials, it is assumed that clinical trial results and the derived clinical evidence have limited generalizability. This creates a gap in needed data and evidence for development of novel therapeutics that will benefit the greatest number of patients, and has most certainly contributed to health care disparities. The next installment of “Real-World Dialogues” will focus on leveraging real-world data, machine learning, and systems biology to enable drug target discovery, drug repurposing, combinatorial therapeutics, and, ultimately, creating evidence to power life-saving decisions for patients and their families.
Webinar
The path to revolutionized cancer care: Accessing data to rapidly generate patient insights to impact care
March 10, 2022
Cancer Care is being revolutionized with real-world data, which tells a comprehensive story for cancer patients. Oncology and technology leaders are always searching for creative approaches to reduce the complexity of exchanging data across multiple platforms. However, when making a sizable investment in getting access to the data you need to inform clinical decision-making, it’s essential to have an engine that can provide out–of–the–box capabilities and the flexibility to manage customizations. In this fireside chat, health-tech experts from Syapse and Infor will discuss the benefits of working in tandem to streamline oncology data acquisition to improve outcomes for cancer patients.
News
01/10/2022
Achieving Comprehensive Patient Care Using Natural Language Processing
Telehealth has seen unprecedented growth within the past few years. As a result of this adoption, at the onset of the COVID-19 pandemic, health care organizations were quickly able to adapt their processes from being rooted in in-person care to relying on virtual care.
01/05/2022
Illumina, Syapse Partner on Study of Comprehensive Genomic Profiling in Advanced Cancer
Syapse said on Tuesday that it has partnered with Illumina to assess uptake and…
01/05/2022
Illumina and Syapse Partner on Biomarker Testing Research Across Oncology Practices
Syapse, a real-world evidence company that informs cancer care, announced a partnership with Illumina aimed at assessing the real-world uptake and actionability of comprehensive genomic profiling in the community oncology health system setting.
Press Releases
08/18/2022
Science 37 and Syapse Partner to Enable Faster Patient Enrollment in Oncology Clinical Trials
RESEARCH TRIANGLE PARK and SAN FRANCISCO, August 18, 2022 — Science 37 Holdings, Inc. (Nasdaq: SNCE), the Agile Clinical Trial Operating System™, and Syapse®, a leading real-world evidence company, today announced a partnership to deploy proprietary real-world data intelligence and analytics that will help identify suitable patients for o…
07/27/2022
Syapse Announces $35 Million Growth Investment with Innovatus Capital Partners to Expand Delivery of Real-World Evidence Through Syapse’s Learning Health Network
SAN FRANCISCO, NEW YORK, July 27, 2022 —Syapse®, a leading real-world evidence company dedicated to extinguishing the fear and burden of serious diseases by advancing real-world care, today announced the closing of a $35 million growth funding transaction to expand Syapse’s focus on providing real-world insights to partners and assist them in improving outcomes for people with cancer.
06/14/2022
Syapse, Pierian Announce Genomics Collaboration to Power Precision Oncology
SAN FRANCISCO, June 14, 2022 — Syapse®, a leading real-world evidence company announced with Pierian®, a global leader in advanced clinical genomics technology, a new joint collaboration that will benefit patients of the AdventHealth Cancer Institute in Central Florida. The collaboration combines Syapse’s real-world evidence solutions designe…